A first, no-cost, no-obligation conversation to scope a small pilot — most simply, a clinical-validation study or an innovation convenio. We bring the FDA-cleared engine and the governed platform. The health service brings a set of already-reported cases and a clinical lead to agree what “good” looks like before we begin.

If it works, we have evidence. If it doesn’t, it cost a meeting and a retrospective dataset — and no patient was ever at risk.

That’s the whole ask: let us show you, safely, on your own data.